Gordon W Gribble

This inventor holds 38 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 2 EPO patents, primarily in Synthetic Triterpenoids. Top assignees: Dartmouth College, Reata Pharmaceuticals, Inc., Osteoscreen, Inc.. Active years: 2001-2019.

USPTO Granted Patents = 38 (Patent Applications = 4)

% Patents Active = 57.9

CIPO Patents = 3

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 3.5

ph-index = 17

Forward Citations = 1,095(Granted Patents)

Location History:

Santa Cruz, CA (US) (2001)
Hanover, NH (US) (2011)
Norwich, VT (US) (2001 - 2013)
Lebanon, NH (US) (2005 - 2019)

Company Filing History:

Reata Pharmaceuticals, Inc.

Rutgers, The State University of New Jersey

patents

5. 1 out of 3,690

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

6. 1 out of 15,988

University of California

patents

where one patent can have more than one assignee

Years Active: 2001-2019

Loading Chart...

Areas of Expertise:

Triterpenoids

Cancer Treatment

Bacterial Infection

Synthetic Compounds

Therapeutic Agents

DNA Intercalating

Peptidase Inhibitors

Stem Cell Modulation

Bis-Carbazole

Betulinic Acid

Amino Acid Conjugates

Intercalating Agents

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10501420 - Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole (2019-12-10),

2. 10377716 - Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection (2019-08-13),

3. 10189791 - Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole (2019-01-29),

4. 9896475 - Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole (2018-02-20),

5. 9796679 - Type 4 prepilin peptidase inhibitors and methods of use (2017-10-24),

6. 9790186 - Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection (2017-10-17),

7. 9757359 - Synthetic triterpenoids and methods of use in the treatment of disease (2017-09-12),

8. 9539287 - Triterpenoids and compositions containing the same (2017-01-10),

9. 9290455 - CDDO-Me amino acid conjugates and methods of use (2016-03-22),

10. 9278913 - Therapeutic compounds and methods of use (2016-03-08),

11. 9205113 - Synthetic triterpenoids and methods for modulating stem/progenitor cell gene expression (2015-12-08),

12. 8981144 - Method for synthesizing 2-cyano-3,12-dioxoolean-1, 9(11)-dien-28-oic acid methyl ester and derivatives thereof (2015-03-17),

13. 8975274 - Compositions and methods for treating cancer (2015-03-10),

14. 8921419 - Triterpenoids and compositions containing the same (2014-12-30),

15. 8921340 - Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions (2014-12-30),

Certainly! Here is the article about inventor Gordon W Gribble:

Title: The Innovative Journey of Gordon W Gribble

Introduction: Gordon W Gribble, a talented inventor hailing from Lebanon, NH (US), has made significant contributions in the field of pharmaceutical compositions and bacterial infection prevention. With an impressive portfolio of 38 patents, Gribble continues to drive innovation in the industry.

Latest Patents: Among his latest patents are "Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole" and "Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection." These innovations highlight his expertise in developing novel solutions for healthcare challenges.

Career Highlights: Gribble has held pivotal roles at renowned institutions such as Dartmouth College and Reata Pharmaceuticals, Inc. His relentless pursuit of excellence has led to groundbreaking discoveries in the pharmaceutical sector, showcasing his dedication to advancing medical science.

Collaborations: Throughout his career, Gribble has collaborated with esteemed professionals in the field, including coworkers like Michael B Sporn and Tadashi Honda. These collaborations have not only inspired innovative ideas but have also fostered a culture of teamwork and knowledge-sharing in the industry.

Conclusion: Gordon W Gribble's journey as an inventor exemplifies a commitment to pushing the boundaries of scientific research and developing transformative solutions for complex medical challenges. His remarkable achievements stand as a testament to his ingenuity and unwavering passion for driving innovations that have the potential to impact countless lives.